Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair

Eur J Heart Fail. 2021 Apr;23(4):677-679. doi: 10.1002/ejhf.2002. Epub 2020 Oct 5.

Authors

Magnus J Hagnäs^{1

2}, Carmelo Grasso², Maria Elena Di Salvo², Andrea Sardone², Paola Rapisarda², Matteo Pelliccia², Francesco Dipasquale², Giuseppe Castania², Sarah Mangiafico², Piera Capranzano², Marco Barbanti², Alessandro Denaro², Salvatore Scandura², Timo Mäkikallio³, Davide Capodanno², Corrado Tamburino²

Affiliations

¹ Department of Internal Medicine, Heart smithy, Lapland Central Hospital, Rovaniemi, Finland.
² Cardiac-Thoracic-Vascular and Transplant Department, Azienda Ospedaliero-Universitaria 'Policlinico-Vittorio Emanuele', Catania, Italy.
³ Division of Cardiology, Department of Internal Medicine, Oulu University Hospital, Oulu, Finland.

PMID: 32946191
DOI: 10.1002/ejhf.2002

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cardiac Catheterization
Heart Failure*
Heart Valve Prosthesis Implantation*
Humans
Mitral Valve / surgery
Mitral Valve Insufficiency* / surgery
Prognosis
Treatment Outcome

Grants and funding